The multiple faces of the vasopressin receptors.
Vallotton
M B
MB
Department of Medicine, University of Geneva, Switzerland.
D000818:Animals; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D000242:Cyclic AMP / Q000378:metabolism; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology* / Q000627:therapeutic use; D015232:Dinoprostone / Q000096:biosynthesis; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D006801:Humans; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D009928:Organ Specificity; D051381:Rats; D011945:Receptors, Angiotensin / Q000145:classification* / Q000187:drug effects / Q000502:physiology; D017483:Receptors, Vasopressin; D015290:Second Messenger Systems / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects; D014667:Vasopressins / Q000494:pharmacology / Q000502:physiology*
D001779:Blood Coagulation Factors; D011945:Receptors, Angiotensin; D017483:Receptors, Vasopressin; D014667:Vasopressins; D001127:Arginine Vasopressin; D000242:Cyclic AMP; D003894:Deamino Arginine Vasopressin; D015232:Dinoprostone